Physiology of growth

Annales Nestle

Volumn 65, Issue 3, 2008, Pages 97-108

  Rosenbloom, Arlan L ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Children's Medical Center of North Florida   (United States)

Author keywords

Adolescence; Fetus; Growth hormone; Growth hormone insensitivity; Human growth; Infancy; Insulin like growth factor I; Nutrition; Pituitary differentiation

Indexed keywords

GENE PRODUCT; GROWTH HORMONE; INSULIN; SEX HORMONE; SOMATOMEDIN; SOMATOMEDIN C; THYROID HORMONE;

ADOLESCENT DEVELOPMENT; BONE DEVELOPMENT; CHILD GROWTH; DEVELOPMENTAL STAGE; ENVIRONMENTAL FACTOR; FERTILIZATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GROWTH CURVE; GROWTH PLATE; HORMONAL REGULATION; HUMAN; HUMAN DEVELOPMENT; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; MATERNAL WELFARE; NUTRITIONAL STATUS; PHYSIOLOGY; PRENATAL GROWTH; REVIEW;

EID: 41349112966     PISSN: 05178606     EISSN: 16614011     Source Type: Journal    
DOI: 10.1159/000112232     Document Type: Review

References (66)

1. Jones KL: Smith's Recognizable Patterns of Human Malformation, ed 6. Philadelphia, Saunders, 2005.
2. Rosenbloom AL: Recombinant human insulin-like growth factor-I (rhIGF-I) and rhIGF-I/rhIGF-binding-protein-3:new growth treatment options? J Pediatr 2007;150:7-11.
3. Smith DW: Growth and Its Disorders. Philadelphia, Saunders, 1977.
4. Lampl M, Veldhuis JD, Johnson ML: Saltation and stasis: a model of human growth. Science 1992;258:801-803.
5. Smith DW, Truog W, Rogers JE, et al: Shifting linear growth during infancy: illustration of genetic factors in growth from fetal life through infancy. J Pediatr 1976;89:225-230.
6. Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Pollock BH: Growth in growth hormone insensitivity. Trends Endocrinol Metab 1994;5:296-303.
7. Root AW, Diamond FB Jr: Overgrowth syndromes: evaluation and management of the child with excessive linear growth; in Lifshitz F (ed): Pediatric Endocrinology, ed 5. New York, Informa Health Care, 2007, vol 2, pp 163-194.
8. Habicht J-P, Martorelli R, Yarborough C, et al: Height and weight standards for preschool children. Lancet 1974;i:1051-1052.
9. Martorelli R: Genetics, environment and growth: Issues in the assessment of nutritional status; in Velazquez A, Bourges H (eds): Genetic Factors in Nutrition. New York, Academic Press, 1985.
10. Olney RC, Bukulmez H, Bartels CF, et al: Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. J. Clin Endocrinol Metab 2006;91:1229-1232.
11. Weber FT, Donnelley WH, Behar RL: Hypopituitarism following extirpation of a pharyngeal pituitary. Am J Dis Child 1977;131:525-528.
12. Junqueira LC, Carneiro J: Basic Histology, ed 3. Los Altos, Lange Medical, 1980, pp 410-420.
13. Cohen LE: Genetic regulation of the embryology of the pituitary gland and somatotrophs. Endocrine 2000;12:99-106.
14. Dattani M, Martinez-Barbera J-P, Thomas PQ: Mutations in the homeobox gene HESX1/HESX1 associated with septo optic dysplasia in human and in mouse. Nat Genet 1998;19:125-133.
15. Cohen RN, Cohen LE, Botero D, et al: Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. J Clin Endocrinol Metab 2003;88:4832-4839.
16. Cohen LE, Radovick S: Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 2002;23:431-442.
17. Zhadanov AB, Bertuzzi S, Taira M, et al: Expression pattern of the murine LIM class homeobox gene Lhx3 in subsets of neural and neuroendocrine tissues. Dev Dyn 1995;202:354-364.
18. Netchine I, Sobrier M-L, Krude H, et al: Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet 2000;25:182-186.
19. Machinis K, Pantel J, Netchine I, et al: Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet 2001;69:961-968.
20. Roessler EYZ, Mullor JL, Casas E, et al: Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proc Natl Acad Sci USA 2003;100:13424-13429.
21. Solomon NM, Nouri S, Warne GL, et al: Increased gene dosage at Xq26-q27 is associated with X-linked hypopituitarism. Genomics 2002;79:553-559.
22. Solomon NM, Ross SA, Morgan T, et al: Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. J Med Genet 2004;41:669-678.
23. Laumonnier F, Ronce N, Hamel BC, et al: Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. Am J Hum Genet 2002;71:1450-1455.
24. Woods KS, Cundall M, Turton J, et al: Overand underdosage of SOX3 is associated with infundibular hypoplasia and hypopituitarism. Am J Hum Genet 2005;76:833-849.
25. Bottner A, Keller E, Kratzsch J, et al: PROP1 mutations cause progressive deterioration of anterior function including adrenal insufficiency: a longitudinal analysis. J Clin Endocrinol Metab 2004;89:5256-5265.
26. Reynaud R, Chadli-Chaieb M, Vallette-Kasic S, et al: A familial form of congenital hypopituitarism due to a PROP1 mutation in a large kindred: phenotypic and in vitro functional studies. J Clin Endocrinol Metab 2004;89:5779-5786.
27. Voutetakis A, Argyropoulou M, Sertedaki A, et al: Pituitary magnetic resonance imaging in fifteen patients with PROP1 gene mutations: pituitary enlargement may originate from the intermediate lobe. J Clin Endocrinol Metab 2004;89:2200-2206.
28. Rosenbloom AL, Selman-Almonte A, Brown MR, et al: Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of PROP-1 gene. J Clin Endocrinol Metab 1999;84:50-57.
29. Turton JP, Reynaud R, Mehta A, et al: Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab 2005;90:4762-4770.
30. Maheshwari HG, Silverman BL, Dupuis J, Baumann G: Phenotypic and genetic analysis of a syndrome caused by an inactivating mutation in the GH releasing hormone receptor: dwarfism of Sindh. J Clin Endocrinol Metab 1998;83:4065-4074.
31. Murray RA, Maheshwari HG, Russell EJ, Baumann G: Pituitary hypoplasia in patients with a mutation in the growth hormone-releasing hormone receptor gene. Am J Neuroradiol 2000;21:685-689.
32. Salvatori R, Fan X, Phillips JA 3rd, et al: Three new mutations in the gene for the growth hormone (GH)-releasing hormone receptor in familial isolated GH deficiency type Ib. J Clin Endocrinol Metab 2001;86:273-279.
33. Keller RJ, Wolfsdorf JI: Isolated growth hormone deficiency after cerebral edema complicating diabetic ketoacidosis. N Engl J Med 1987;316:857-859.
34. Netter FH: The CIBA Collection of Medical Illustrations. Vol 4: Endocrine System and Selected Metabolic Diseases. Chicago, Donnelley & Sons, 1964, section 1, plate 2.1.
35. Lewis UJ, Singh RNP, Tutwiler GH, et al: Human growth hormone: a complex of proteins. Recent Prog Horm Res 1980;36:477-508.
36. Bowers CY, Momany F, Reynolds GA, Hong A: On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984;114:1531-1536.
37. Goth MI, Lyons CE, Canny BJ, Thorner MO: Pituitary adenylate cyclase activating polypeptides, growth hormone (GH) releasing peptide and GH releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 1992;130:939-944.
38. Kojima M, Hosada H, Date Y, et al: Ghrelin is a growth hormone releasing acetylated peptide from stomach. Nature 1999;402:656-660.
39. Bowers CY: Unnatural growth hormone-releasing peptide begets natural ghrelin. J Clin Endocrinol Metab 2001;86:1464-1469.
40. Korbonits M, Bustin SA, Kojima M, et al: The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors. J Clin Endocrinol Metab 2001;86:881-887.
41. Konturek PC, Konturek JW, Czesnikiewicz-Guzik M, et al: Neuro-hormonal control of food intake; basic mechanisms and clinical implications. J Physiol Pharmacol 2005;56(suppl 6):5-25.
42. Postel-Vinay MC, Kelly PA: Growth hormone receptor signalling. Baillieres Clin Endocrinol Metab 1996;10:323-326.
43. Ymer SI, Herrington AC: Evidence for the specific binding of growth hormone to a receptor like protein in rabbit serum. Mol Cell Endocrinol 1985;41:153-161.
44. Daughaday WH, Trivedi B: Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism). Proc Natl Acad Sci USA 1987;84:4636-4640.
45. Baumann G, Shaw MA, Winter RJ: Absence of plasma growth hormone-binding protein in Laron-type dwarfism. J Clin Endocrinol Metab 1987;65:814-816.
46. Leung DW, Spencer SA, Cachianes G, et al: Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987;330:537-543.
47. Godowski PJ, Leung DW, Meacham LR, et al: Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 1989;86:8083-8087.
48. Kelly PA, Nagano M, Sotiropoulos A, et al: Growth hormone-prolactin receptor gene family; in Shiverick KT, Rosenbloom AL (eds): Human Growth Hormone Pharmacology: Basic and Clinical Aspects. Boca Raton, CRC Press, 1995, pp 13-28.
49. de Vos AM, Ultsch M, Kossiakoff AA: Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 1992;255:306-312.
50. Campbell GS: Growth-hormone signal transduction. J Pediatr 1997;131:S42-S44.
51. Rosenfeld RG, Belgorosky A, Camacho-Hubner C, et al: Defects in growth hormone receptor signaling. Trends Endocrinol Metab 2007;18:134-141.
52. Dastot F, Sobrier ML, Duquesnoy P, et al: Alternative spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH binding protein. Proc Natl Acad Sci USA 1996;93:10723-10728.
53. Fisker S, Kristensen K, Rosenfalck AM, et al: Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment. J Clin Endocrinol Metab 2001;86:792-796.
54. Rosenbloom AL, Connor EL: Hypopituitarism and other disorders of the growth hormone-insulin-like growth factor-I axis; in Lifshitz F (ed): Pediatric Endocrinology, ed 5. New York, Informa Health Care, 2007, vol 2, pp 65-99.
55. de Lima Jorge AA, de Menezes Filho HC, Soares Lins TS, et al: Founder effect of E180-splice mutation in growth hormone receptor gene (GHR) identified in Brazilian patients with GH insensitivity. Arq Bras Endocrinol Metabol 2005;49:384-389.
56. van der Eerden BC , Karperien M, Wit JM: Systemic and local regulation of the growth plate. Endocr Rev 2003;24:782-801.
57. Isaksson OG, Lindahl A, Nilsson A, Isgaard J: Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth. Endocr Rev 1987;8:426-438.
58. Rinderknecht E, Humbel RE: The amino acid sequence of human insulin like growth factor I and its structural homology with proinsulin. J Biol Chem 1978;253:2769-2776.
59. Rinderknecht E, Humbel RE: Primary structure of human insulin like growth factor II. FEBS Lett 1978;89:283-287.
60. Baxter RG, Binoux MA, Clemmons DR, et al: Recommendations for nomenclature of the insulin-like growth factor binding proteins superfamily. J Clin Endocrinol Metab 1998;83:3213.
61. Domene HM, Bengolea SV, Jasper HG, Boisclair YR: Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse. J Endocrinol Invest 2005;28(suppl):43-46.
62. Vaccarello MA, Diamond FB Jr, Guevara-Aguirre J, et al: Hormonal and metabolic effects and pharmacokinetics of recombinant human insulin-like growth factor-I in GH receptor deficiency/Laron syndrome. J Clin Endocrinol Metab 1993;77:273-280.
63. Collett-Solberg PF, Cohen P: Genetics, chemistry, and function of the IGF/IGFBP system. Endocrine 2000;12:121-136.
64. Giudice LC, de Zegher F, Gargosky SE, et al: Insulin like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab 1995;80:1548-1555.
65. Geffner ME: The growth without growth hormone syndrome. Endocrinol Metab Clin North Am 1996;25:649-663.
66. Phillip M, Moran O, Lazar L: Growth without growth hormone. J Pediatr Endocrinol Metab 2002;15(suppl 5):1267-1272.